Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000347533

Medchemexpress LLC N-Octanoyl-D-erythro-sphingosine | 74713-59-0 | 98.0% | 425.69 | 25 MG
SDP

Catalog No. 5000347533
Encompass_Preferred

C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. It has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections and induces slight activation of protein kinase (PKC) in vitro.

  • Cell-permeable analog of naturally occurring ceramides
  • Has anti-proliferation properties
  • Acts as a potent chemotherapeutic agent
  • Stimulates dendritic cells to promote T cell responses upon virus infections
  • Induces slight activation of protein kinase (PKC) in vitro

Catalog No. 50-003-47533 Supplier Medchemexpress LLC Supplier No. 25MGHY108391
May include imposed supplier surcharges.
Add to Cart
Add to Cart

C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. It has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections and induces slight activation of protein kinase (PKC) in vitro.

  • Cell-permeable analog of naturally occurring ceramides
  • Has anti-proliferation properties
  • Acts as a potent chemotherapeutic agent
  • Stimulates dendritic cells to promote T cell responses upon virus infections
  • Induces slight activation of protein kinase (PKC) in vitro

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.